Modified Application of Cardiac Rehabilitation in Older Adults (MACRO) Trial: Protocol changes in a pragmatic

Daniel E Forman1, Susan B Racette2, Pamela E Toto3

  • 1University of Pittsburgh, Divisions of Geriatrics and Cardiology, and Pittsburgh Veteran Affairs, GRECC, Pittsburgh, PA, United States of America.

Insights

The Modified Application of Cardiac Rehabilitation in Older Adults (MACRO) trial uses a novel coaching intervention to boost enrollment and functional recovery in older adults undergoing cardiac rehabilitation (CR). This approach addresses age-related participation barriers in CR programs.

Area of Science:

  • Gerontology
  • Cardiology
  • Clinical Trials

Background:

  • Older adults face increased risks of cardiovascular disease and functional decline.
  • Cardiac rehabilitation (CR) improves recovery but has low participation rates among older individuals.
  • The Modified Application of CR in Older Adults (MACRO) trial aims to increase CR enrollment and functional outcomes in this demographic.

Purpose of the Study:

  • To describe the methodology and novel features of the MACRO trial.
  • To investigate an individualized coaching intervention to enhance CR participation in older adults.
  • To improve clinical and functional recovery in older adults post-cardiac hospitalization.

Main Methods:

  • A randomized, controlled trial comparing a coaching intervention (MACRO-I) with usual care for adults aged 70+ eligible for CR.
  • MACRO-I includes holistic assessments, flexible CR formats, motivational support, nutritional focus, deprescription, education, and home visits.
  • The primary endpoint shifted from performance-based to patient-reported due to COVID-19, maintaining the trial's core objectives.

Main Results:

  • The MACRO trial is exploring a novel coaching intervention for older CR patients.
  • Modifications due to COVID-19 were implemented while preserving the trial's primary objective.
  • Updated protocols are expected to more effectively achieve the study's original goals.

Conclusions:

  • The MACRO trial employs an innovative coaching strategy to improve older adults' engagement with cardiac rehabilitation.
  • Protocol adjustments necessitated by the COVID-19 pandemic were managed to maintain study integrity.
  • The revised methodology is anticipated to enhance the achievement of the trial's primary aims.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
390
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
64
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
53
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
23
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
18
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.6K